Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
National Cancer Institute (NCI)
Henan Cancer Hospital
International Extranodal Lymphoma Study Group (IELSG)
Beth Israel Deaconess Medical Center
University of Washington
The First Affiliated Hospital with Nanjing Medical University
Massachusetts General Hospital
University of Ulm
First Affiliated Hospital of Zhejiang University
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Sun Yat-sen University
University of Utah
Second Affiliated Hospital, School of Medicine, Zhejiang University
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital with Nanjing Medical University
University of California, Davis
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital of Nanchang University
University of Miami
University of Ulm
BeiGene
Academic and Community Cancer Research United
City of Hope Medical Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Chinese PLA General Hospital
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
Universität des Saarlandes
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University of Washington
University of Arizona
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Memorial Sloan Kettering Cancer Center